PECAM-1 overexpression signifies aggressive biologic behavior of oral lichen planus - A pilot study

Indian J Dent Res. 2020 Mar-Apr;31(2):277-281. doi: 10.4103/ijdr.IJDR_653_18.

Abstract

Context: The etiopathogenesis of oral lichen planus (OLP) is still debatable. According to literature, many studies have illustrated OLP as a T-cell-mediated chronic autoimmune disease. Currently, there is increased evidence of chronic inflammation in OLP and its association with vascular adhesion molecules (VAMs).

Aim: The aim of this study was to evaluate the expression of VAM (PECAM-1) in OLP.

Setting and design: Tissue samples involved 20 archival cases of histopathologically confirmed OLP (n = 15) and normal mucosa (n = 5) as controls.

Materials and methods: The sections were subjected to immunohistochemical analysis using antibody to PECAM-1. Brown staining of the endothelial cells of blood vessels was considered positive. The expression of PECAM-1 in OLP was statistically analyzed using Wilcoxon sign-rank test.

Results: The expression of PECAM-1 in OLP was statistically significant when compared with normal mucosa (P < 0.05). A statistically significant difference was also observed in PECAM-1 expression between the reticular type and erosive type of OLP.

Conclusion: PECAM-1 was found to be overexpressed in OLP; difference in PECAM-1 expression was noted between the reticular and erosive types. The VAMs could be exploited as a possible therapeutic target in OLP to modulate the disease process thereby reducing the dependency on corticosteroids.

Keywords: Inflammation; PECAM-1; oral lichen planus; vascular adhesion molecules.

MeSH terms

  • Biological Products*
  • Endothelial Cells
  • Humans
  • Lichen Planus, Oral*
  • Pilot Projects
  • Platelet Endothelial Cell Adhesion Molecule-1

Substances

  • Biological Products
  • Platelet Endothelial Cell Adhesion Molecule-1